FindTrial
Sign In

Placebo and Nocebo Effects in Patients With Takotsubo Cardiomyopathy and Heart-Healthy Controls

Placebo and Nocebo Effects in Patients With Takotsubo Cardiomyopathy and Heart-Healthy Controls - CaRe

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009296
Enrollment
40
Registered
2015-10-27
Start date
2015-11-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I42.88

Interventions

Group 1: Arm 1: Patients with Stressinduced Cardiomyopathy (according to Mayo clinic diagnostic criteria) Group 2: Arm 2: Heart-healthy controls (katheder-confirmed) matched according to age and sex

Sponsors

Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Klinikum rechts der Isar der Technischen Universität, München
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Women, diagnosed with TTC, and 20 volunteers (CG) free of significant coronary artery disease (vessel stenosis =30%, confirmed via heart catheterization in the past) TTC patients diagnosed regarding Mayo Clinic’s diagnostic criteria for akotsubo Cardiomyopathy.

Exclusion criteria

Exclusion criteria: Participants with significantly decreased ejection fraction (<55%) or low German proficiency, malignant primary disease

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure, diastolic blood pressure, heart rate, subjective units of distress—

Secondary

MeasureTime frame
Copeptin, cortisol—

Countries

Germany

Contacts

Public ContactElisabeth Olliges

Institut für Medizinische Psychologie der Ludwig-Maximilians Universität, München

elisabeth.olliges@med.uni-muenchen.de2180-75642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 20, 2026